Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

A Study Assessing the Long-Term Safety and Tolerability of Galegenimab (FHTR2163) in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

ClinicalTrials.gov ID: NCT04607148

Public ClinicalTrials.gov record NCT04607148. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 8:53 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety and Tolerability of Intravitreal Injections of FHTR2163 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the long-term safety and tolerability of intravitreal (ITV) injections of galegenimab (FHTR2163) administered every 4 weeks (Q4W) or every 8 weeks (Q8W) in participants with geographic atrophy (GA) secondary to age-related macular degeneration (AMD) who completed the parent study (NCT03972709/GR40973).

Study identification

NCT ID
NCT04607148
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Genentech, Inc.
Industry
Enrollment
144 participants

Conditions and interventions

Eligibility (public fields only)

Age range
60 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 15, 2020
Primary completion
Nov 13, 2022
Completion
Nov 13, 2022
Last update posted
Oct 15, 2023

2020 – 2022

United States locations

U.S. sites
48
U.S. states
22
U.S. cities
46
Facility City State ZIP Site status
California Retina Consultants Bakersfield California 93309
The Retina Partners Encino California 91436
Retina Consultants of Orange County Fullerton California 92835-3424
Northern California Retina Vitreous Associates Mountain View California 94040
Retina Consultants, San Diego Poway California 92064
Retinal Consultants Med Group Sacramento California 95825
West Coast Retina San Francisco California 94109-5520
California Retina Consultants Santa Barbara California 93103
California Retina Consultants - Santa Maria Santa Maria California 93454
Bay Area Retina Associates Walnut Creek California 94598
Retina Consultants of Southern Colorado PC Colorado Springs Colorado 80909
Southwest Retina Consultants Durango Colorado 81303
Colorado Retina Associates, PC Lakewood Colorado 80228
Rand Eye Deerfield Beach Florida 33064
Florida Eye Associates - Melbourne 2nd Office Melbourne Florida 32901
Retina Specialty Institute Pensacola Florida 32503
Retina Vitreous Assoc of FL St. Petersburg Florida 33711
Southern Vitreoretinal Associates Tallahassee Florida 32308
Southeast Retina Center Augusta Georgia 30909
Georgia Retina PC Marietta Georgia 30060-1137
Illinois Eye and Ear Infirmary Chicago Illinois 60612
Wolfe Eye Clinic West Des Moines Iowa 50266
Vitreo Retinal Consultants Wichita Kansas 67214
Johns Hopkins University Baltimore Maryland 21287
Vitreo-Retinal Associates Grand Rapids Michigan 49546
Associated Retinal Consultants PC Royal Oak Michigan 48073
Midwest Vision Research Foundation Chesterfield Missouri 63017
The Retina Institute St Louis Missouri 63128
Sierra Eye Associates Reno Nevada 89502
NJ Retina Teaneck Clinic Toms River New Jersey 08755
NJ Retina-Toms River Toms River New Jersey 08755
Ophthalmic Consultants of Long Island Oceanside New York 11572
Western Carolina Retinal Associate PA Asheville North Carolina 28803
Charlotte Eye Ear Nose and Throat Associates PA Charlotte North Carolina 28210
Cincinnati Eye Institute Cincinnati Ohio 45242
Cleveland Clinic Foundation; Cole Eye Institute Cleveland Ohio 44195-0001
Casey Eye Institute Portland Oregon 97239
Mid Atlantic Retina - Wills Eye Hospital Philadelphia Pennsylvania 19107
Palmetto Retina Center West Columbia South Carolina 29169
Southeastern Retina Associates Chattanooga Chattanooga Tennessee 37421
Charles Retina Institute Germantown Tennessee 38138
Tennessee Retina PC Nashville Tennessee 37203
Austin Retina Associates Austin Texas 78705-1169
Austin Clinical Research LLC Austin Texas 78750
Retina Foundation of the Southwest Dallas Texas 75231
Retina Consultants of Texas The Woodlands Texas 77384-4167
Spokane Eye Clinical Research Spokane Washington 99204
University of Wisconsin Madison Wisconsin 53705

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04607148, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 15, 2023 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04607148 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →